Clinical Trial Update: A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update announcing a Phase 1/2 study to evaluate safety and efficacy of VGN-R09b for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• VGN-R09b

Snippet

Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING